Opioid litigation retains open vaults of nice pharmaceutical secrets and techniques
Law360 (March 5, 2021, 7:57 p.m. EST) – In a revelation with few historical parallels, major drug companies are poised to resolve large-scale opioid disputes by agreeing to publish millions of pages of internal documents that illustrate how they use narcotics Have marketed and sold pain medication amid a major addiction epidemic, according to attorneys and court records.
Several companies, including OxyContin maker Purdue Pharma LP, have tacitly signed contracts to allow records privately disclosed during the current wave of opioid litigation to be posted online for all to see. And when prosecutors general and plaintiffs attorneys find their way, many more companies will do the same in future opioid settlements.
“Disclosure of documents …
Stay ahead of the curve
In the legal profession, information is the key to success. You need to know what is happening to customers, competitors, areas of activity, and industries. Law360 has the information you need to stay an expert and beat the competition.
- Access to case data in articles (numbers, filings, courts, type of lawsuit, etc.)
- Access to attached documents such as Briefs, petitions, complaints, decisions, motions, etc.
- Create custom notifications for specific article and case topics, and more!
TRY LAW360 FREE FOR SEVEN DAYS